SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 185.97-0.4%Feb 10 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bob smith who wrote (6778)9/17/1997 8:55:00 AM
From: Henry Niman   of 32384
 
bob, Thanks for the headsup on the CalBio Summit. I knew LGND was presenting, but I wasn't sure if the conference was more science or more financial. Its bigger and more financially orientated than I realized. LGND will also be presenting at a couple of large scientific meetings at about the same time. One is in San Diego next week and its on "Transcription Regulation and Signal Transduction"
ibcusa.com
and the other is in Philadelphia on "Insulin Resistance" October 6-7:
ibcusa.com
Here's the Transcription Regulation scheduled topics:
JAK/STAT Signaling Pathway
Orally Bioavailable Small
Molecule Drugs
Novel Small Molecule
Inhibitors
Transcription Factors with
Therapeutic Applications
Mediating the Immune
Response
Transcriptional Potential of
NF-AT
Growth Suppressor/Kinase
Regulation of E2F
Chromatin-Mediated
Repression
Animal Models
Rexinoid Treatment of
NIDDM
Nuclear Hormone Receptors
Effects of Bacterial Endotoxin
on Innate Immune System
Regulation and Structure of
MAP Kinases
Inhibitor of AP-1 Mediated
Gene Activation
Calcium/Calcineurin Signaling
Pathway
Steroid Hormones
Cell Cycle and Cell Death
Both conferences will include Ligand presentations on Rexinoids.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext